Get the latest Science News and Discoveries

FDA approves drug for patients with HR+, HER2+ advanced breast cancer based on results from alliance foundation trials PATINA trial - EurekAlert!

Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Related news:

UT San Antonio study: As FDA approved semaglutide for weight management, calls to poison control centers skyrocketed in the U.S. - EurekAlert!

From biopsy to biomarker: Hollings researchers detail how long patients wait for results - EurekAlert!

A phase I-II study of niacin in patients with newly diagnosed glioblastoma: safety and interim phase II analysis